IRIS
OYEN, Willem Jozef Gerard
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.558
AS - Asia 11.627
EU - Europa 4.997
SA - Sud America 2.483
AF - Africa 1.092
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 19
Totale 58.824
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.132
SG - Singapore 8.445
BR - Brasile 2.232
CN - Cina 1.717
FI - Finlandia 1.367
IE - Irlanda 1.055
NG - Nigeria 913
FR - Francia 576
DE - Germania 565
NL - Olanda 395
HK - Hong Kong 382
GB - Regno Unito 341
CA - Canada 296
IT - Italia 244
TR - Turchia 163
IN - India 146
VN - Vietnam 135
BD - Bangladesh 106
SE - Svezia 100
IL - Israele 98
RU - Federazione Russa 91
AR - Argentina 76
IQ - Iraq 72
MX - Messico 70
ZA - Sudafrica 62
JP - Giappone 52
UA - Ucraina 45
ES - Italia 42
PK - Pakistan 40
PL - Polonia 40
UZ - Uzbekistan 37
AU - Australia 34
VE - Venezuela 32
MA - Marocco 31
CL - Cile 30
IR - Iran 30
CO - Colombia 29
EC - Ecuador 29
SA - Arabia Saudita 27
KE - Kenya 23
AE - Emirati Arabi Uniti 22
ID - Indonesia 22
JO - Giordania 21
PY - Paraguay 20
CZ - Repubblica Ceca 19
EG - Egitto 19
TN - Tunisia 19
AZ - Azerbaigian 17
NP - Nepal 17
AT - Austria 14
JM - Giamaica 14
A2 - ???statistics.table.value.countryCode.A2??? 13
LB - Libano 13
PE - Perù 13
RO - Romania 13
NZ - Nuova Zelanda 12
BO - Bolivia 11
KZ - Kazakistan 11
BE - Belgio 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
UY - Uruguay 10
CH - Svizzera 9
GR - Grecia 9
OM - Oman 9
PA - Panama 9
HN - Honduras 8
LT - Lituania 8
MD - Moldavia 8
DK - Danimarca 7
RS - Serbia 7
SN - Senegal 7
MY - Malesia 6
NO - Norvegia 6
PS - Palestinian Territory 6
AL - Albania 5
BB - Barbados 5
BH - Bahrain 5
XK - ???statistics.table.value.countryCode.XK??? 5
TW - Taiwan 4
BG - Bulgaria 3
CR - Costa Rica 3
NI - Nicaragua 3
PH - Filippine 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
KR - Corea 2
KW - Kuwait 2
LI - Liechtenstein 2
LK - Sri Lanka 2
MN - Mongolia 2
PT - Portogallo 2
QA - Qatar 2
AM - Armenia 1
AO - Angola 1
Totale 58.796
Salva come PNG Salva come JPEG
Città #
Chandler 7.378
Wilmington 6.853
San Mateo 2.586
Singapore 2.553
The Dalles 2.232
Ann Arbor 1.402
Shanghai 1.378
Helsinki 1.365
Leawood 1.222
Lawrence 1.117
Princeton 1.117
Dublin 1.050
Boardman 1.009
Benin City 911
Ashburn 777
Fairfield 684
Woodbridge 647
New York 629
Dallas 615
Paris 557
Amsterdam 377
Seattle 363
Hong Kong 360
San Diego 315
Beijing 231
London 231
Toronto 208
São Paulo 186
Los Angeles 134
Norwalk 128
Kocaeli 103
Milan 103
Rio de Janeiro 77
Belo Horizonte 68
Santa Clara 67
Phoenix 61
Brooklyn 54
Falkenstein 53
Ho Chi Minh City 52
Houston 41
Tokyo 41
Brasília 39
Chicago 39
Pune 39
Porto Alegre 35
Montreal 33
Tashkent 33
Moscow 32
Reston 32
Dhaka 31
Johannesburg 31
Monmouth Junction 30
Munich 30
Redmond 29
Campinas 28
Warsaw 28
Des Moines 27
Stockholm 27
Boston 26
Curitiba 25
Hanoi 25
San Jose 24
Baghdad 23
Istanbul 21
Council Bluffs 20
Mexico City 20
Salvador 20
Amman 19
Orem 19
Ribeirão Preto 19
Charlotte 18
Denver 18
San Francisco 18
Chennai 17
Fortaleza 17
Nairobi 17
Guarulhos 15
Hangzhou 15
Manchester 15
Baku 14
Cambridge 14
Clearwater 14
Erbil 14
Goiânia 14
Juiz de Fora 14
Naples 14
Sorocaba 14
Asunción 13
Atlanta 13
Caracas 13
Hanover 13
Manaus 13
New Delhi 13
São José dos Campos 13
Andover 12
Cape Town 12
Caxias do Sul 12
Contagem 12
Maringá 12
Osasco 12
Totale 40.564
Salva come PNG Salva come JPEG
Nome #
(18)FDG-PET for staging (non)seminomatous germ cell tumours [(N)SGCT] and for evaluation of postchemotherapy residual masses. 105
18-F fluorodeoxygenase (FDG) positron emission tomography (PET) scanning prior to radical lung radiotherapy. A retrospective audit of practice 101
2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: A prospective study 96
18F-FLT-PET for the evaluation of MEK inhibitor AZD6244 87
[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer 86
Abscopal effect of radiotherapy in a patient with metastatic diffuse-type giant cell tumor 84
The Role of FDG-PET in the Assessment of Thyroid Nodules with an Indeterminant or Suspicious Cytologic Diagnosis 84
F-18-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation 84
Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients 84
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 82
Effect of the positron range on the spatial resolution of a new generation pre-clinical PET using fluorine-18, gallium-68, zirconium-89 and iodine-124 82
F-18-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis 82
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 81
F-18-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis 81
New targeted probes for radioimaging of angiogenesis 81
F-18-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients 81
[F-18]-Fluorination of a Leukotriene B4 Receptor Antagonist via Hydrazone Formation and its Application in Infection Imaging 81
F-18-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis 80
[F-18]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma 80
3 '-Deoxy-3 '-F-18-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients 80
18F-FDG PET/CT in Detecting Metastatic Infection in Children 79
PET-CT for response assessment and treatment adaptation in head and neck cancer 78
Kidney protection during peptide receptor radionuclide therapy (PRRT) 78
A direct comparison of four different Ga-68-labeled RGD peptides for PET/CT imaging of angiogenesis 78
F-18-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality 78
99mTc-interleukin-8 for imaging acute osteomyelitis 77
[F-18]fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic e-cadherin mutation carrier 77
7TH ANNUAL-MEETING OF THE INTERNATIONAL RESEARCH GROUP IN IMMUNOSCINTIGRAPHY AND IMMUNOTHERAPY 76
Improved selection of patients for hepatic surgery of colorectal liver metastases with FDG-PET: A randomized study 76
Radioimmunotherapy with I-131-cG250 monoclonal antibody in patients with metastasized RCC, a phase I/II study. 76
F-18-FDG PET AS A PREDICTOR OF PULMONARY FUNCTION IN SARCOIDOSIS 76
Comparison of liver SUV using unenhanced CT versus contrast- enhanced CT for attenuation correction in 18 F-FDGPET/CT 75
F-18-FDG PET of thyroid nodules with inconclusive cytologic results - Reply 75
Background-subtracted optimal threshold segmentation algorithm for FDG-PET based GTV delineation: Theory and experimental validation 75
18F-FDG-PET reduces the number of direct laryngoscopies in patients with suspected recurrent laryngeal carcinoma after radiotherapy 75
The role of megalin in the renal uptake of radiolabeled peptides 74
Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer 74
A bivalent leukotriene B-4 antagonist for scintigraphic Imaging of infectious foci 74
Megalin Plays an Important Role in the Renal Uptake of Various Radiolabeled Peptides: Studies in Megalin-Deficient Mice 74
A 3-step pretargeting strategy to image infection 74
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 74
INTERIM ANALYSIS OF A PHASE I RADIOIMMUNOTHERAPY STUDY IN ADVANCED RENAL CELL CARCINOMA PATIENTS USING LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250 73
F-18-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive Bacteremia 73
Dynamic FDG PET in liver metastases of colorectal cancer: repeatability of dynamic and static FDG PET parameters. 73
Clinical application of FDG-PET/CT in metastatic infections 73
SPECT/CT-based Dosimetry for a Multicentre Trial of Selumetinib Enhanced Radioiodine Treatment of Differentiated Thyroid Cancer: Preliminary Results 72
Development of Radiotracers for the Determination of the Beta-Cell Mass In Vivo 72
WHICH FACTORS PREDICT THE RESULTS OF PITUITARY SURGERY IN ACROMEGALY 72
Ga-68-labelled exendin-3, a new agent for the detection of insulinomas with PET 72
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer 72
Albumin derived peptides efficiently reduce renal uptake of radiolabeled peptides 71
Pretargeted immuno-PET imaging and radioimmunotherapy of prostate cancer with an anti-EGP1 x anti-HSG bispecific antibody 71
CAN FOG-PET PREDICT RADIATION TREATMENT OUTCOME IN HEAD AND NECK CANCER? 71
Evaluation of the advanced ReSPECT image reconstruction software in a phantom model and in parathyroid scanning 71
FDG-PET and CT in the staging of melanoma patients with lymph node metastases; diagnostic performance and clinical consequences 71
Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: Report of a case 71
Radiation Exposure (Un)Awareness amongst nuclear medicine patients - a systematic review 71
Reducing renal uptake of radiolabeled peptides using albumin fragments 70
F-18-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors 70
Procedure guidelines for PET/CT tumour imaging with Ga-68-DOTA-conjugated peptides: Ga-68-DOTA-TOC, Ga-68-DOTA-NOC, Ga-68-DOTA-TATE 70
INDIUM-111-LABELED HUMAN NONSPECIFIC IMMUNOGLOBULIN-G - A NEW RADIOPHARMACEUTICAL FOR IMAGING INFECTIOUS AND INFLAMMATORY FOCI 70
Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss 70
EANM Focus 1: one small step for two men, one giant leap for a specialty 70
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer 70
Spatial resolution of the Inveon small-animal PET scanner for the entire field of view 70
Validated image fusion of dedicated PET and CT for external beam radiation therapy in the head and neck area 70
In-111-anti-F4/80 for in vivo tracking of tumor associated macrophages 70
RADIOIMMUNOCONJUGATES IN THE DETECTION OF INFECTION AND INFLAMMATION 70
SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA 69
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 69
SPECIFIC ANTIBODY UPTAKE IN TUBERCULOSIS 69
Molecular Imaging and Theranostics-A Multidisciplinary Approach 69
F-18-FDG PET/CT in Local Ablative Therapies: A Systematic Review 69
In-111-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib 69
Radiopharmaceuticals to image infection and inflammation 69
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy 69
Imaging of Prostate Cancer with Immuno-PET and Immuno-SPECT Using a Radiolabeled Anti-EGP-1 Monoclonal Antibody 69
The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma 69
F-18-fluorodeoxyglucose positron emission tomography of colonic anastomosis: A possibility to detect anastomotic leakage? A pilot study 69
PET and SPECT Imaging of a Radio labeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with Cu-64, Ga-68, and In-111 69
LOCALIZATION OF INFECTION IN HIV ANTIBODY-POSITIVE PATIENTS WITH FEVER - COMPARISON OF THE EFFICACY OF GA-67-CITRATE AND RADIOLABELED HUMAN-IGG 68
Radiolabeled IL-1ra for detection of synovitis in patients with RA. Preliminary results. 68
Macrophage targeting in experimental arthritis 68
FDG-PET in diagnosing central venous catheter related infection in stem cell transplant recipients 68
Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET 68
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using Ga-68-RGD PET/CT 68
IMPROVED SELECTION OF PATIENTS FOR HEPATIC SURGERY OF COLORECTAL LIVER METASTASES WITH FDG-PET: RESULTS OF THE RANDOMIZED DUTCH POLEM STUDY 67
SUV: From Silly Useless Value to Smart Uptake Value 67
Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer 67
Molecular imaging of hypoxia 67
Progress in nuclear medicine procedures in head and neck oncology 67
Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring 67
Incidental finding of malignancy in patients preoperatively evaluated for aneurysm wall pathology using PET/CT 67
Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring F-18-FDG PET studies 67
A modelling approach to estimate the FDG arterial plasma time activity curve in Patlak-based therapy response analysis 66
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise 66
Zirconium-89-girentuximab PET/CT imaging in renal cell carcinoma: first in man results 66
STERICALLY STABILIZED LIPOSOMES LABELED WITH IN-111 TO IMAGE FOCAL INFECTION 66
A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER 66
A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats 66
Totale 7.382
Salva come PNG Salva come JPEG
Categoria #
all - tutte 500.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 500.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.958 0 0 0 0 0 3.755 1.703 568 2.523 2.209 3 1.197
2021/20224.627 79 16 98 1.389 3 6 125 846 434 329 1.015 287
2022/202317.903 2.481 628 1.666 1.827 1.928 1.633 9 1.746 3.329 1.396 999 261
2023/20246.755 651 912 1.757 185 208 613 138 381 91 69 490 1.260
2024/20259.716 186 155 58 29 29 1.005 486 1.576 1.297 2.812 936 1.147
2025/20267.872 3.861 1.005 381 1.706 576 343 0 0 0 0 0 0
Totale 59.048